Cash-rich psychedelic stocks are cheap. They are also building value for investors -- at an accelerating rate.
Articles
Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
Numinus prepares for a Phase I clinical trial of its proprietary psilocybin extract.
Small Pharma Announces Upgrade to the OTCQB® and DTC Eligibility
Small Pharma announces receiving DTC Eligibility and its OTCQB listing to broaden liquidity and increase access for U.S. investors.
Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies
Cybin has completed its 74th pre-clinical study and anticipates commencing human clinical studies in early 2022.
First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial
Small Pharma commences enrolling patients for its Phase IIa DMT-based clinical trial aimed at treating Major Depressive Disorder.
COMPASS Pathways is granted new US patent for crystalline psilocybin
Compass Pathway's fourth U.S. patent covers its Form A hydrate psilocybin, and is the first patent for this formulation.
Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in Seattle, Vancouver and Fredericton
Field Trip is adding three new clinics to its network, with two of the three already open and the third opening imminently.
Real World Evidence (RWE) Drug Development: A Faster/Cheaper Route For Psychedelics
Drug development through the formal clinical trials process is slow and expensive. Real World Evidence (RWE) drug development is fast and cheap. Have we got your attention yet?
Oakland Psychedelics Activists Launch Initiative To Legalize Community-Based Sales With Support From City Council
Oakland activists are hoping to expand upon the city’s current psychedelics decriminalization ordinance by creating a community-based model through which people could legally purchase entheogenic substances from local producers.
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions
Levitee Labs announces a partnership with Adracare Inc., a subsidiary of Well Health Technologies (WELL), to build out a digital therapeutics platform.
Democratic Senators’ Bill Would Let DC Legalize Marijuana Sales In Contrast To Biden’s Proposed Blockade
The Democratic leader of a key U.S. Senate committee on Monday released the text of legislation that, if enacted, would finally allow Washington, D.C. to legalize recreational marijuana sales—in contravention of the wishes of President Joe Biden.
New Mexico Considering $5M Credit Line for Cannabis Microbusinesses
The New Mexico Finance Authority put forward a proposal that opens a $5 million line of credit for cannabis microbusinesses in order to promote social and economic fairness in the cannabis industry, the Associated Press reports.
Democratic Candidates for Florida Governor Vow to Legalize Marijuana
Florida Democratic gubernatorial candidate and congressman Representative Charlie Crist announced on Thursday that he will legalize marijuana and expunge past cannabis-related convictions if he is elected governor.
Singer Melissa Etheridge And Activist Van Jones Promote Psychedelics Reform As Movement Grows
The fight to end the criminalization of psychedelics and give patients access to natural plants and fungi has achieved success in a growing number of cities and states in recent years, and on Thursday the cause got a boost from prominent people in the entertainment and political fields.
USDA to Survey Hemp Farmers
The U.S. Department of Agriculture’s National Agricultural Statistics Service (NASS) plans to send 20,500 hemp producers across the country their first Hemp Acreage and Production Survey, beginning October 18.